🇺🇸 FDA

Intelligence · Clinical Pipeline

Teva Pharma Pipeline

All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.

Programs
39

Quick answer

Teva Pharma has 39 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 16 mg buprenorphine with 4 mg naloxone sublingual film

    Teva Pharma GmbH

    Evaluation of QTc Interval

    approved other terminated

    1 trial

  2. AGEE cream

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule terminated

    1 trial

  3. Advair Diskus100/50 µg

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  4. AirDuo Digihaler

    Teva Pharma GmbH

    Asthma

    approved other completed

    1 trial

  5. Albuterol eMDPI DS

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  6. Albuterol-HFA-MDI

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  7. Alcohol Wipes vs. No Alcohol Wipes

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  8. Alfacalcidol

    Teva Pharma GmbH

    Accidental Falls

    approved small molecule terminated

    1 trial

  9. Armodafinil

    Teva Pharma GmbH

    Excessive Sleepiness

    approved small molecule completed

    3 trials

  10. Armodafinil

    Teva Pharma GmbH

    Menopause

    approved small molecule completed

    1 trial

  11. Beclomethasone (QVAR)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  12. Copaxone

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  13. Deutetrabenazine

    Teva Pharma GmbH

    Huntington's Disease

    approved small molecule completed

    1 trial

  14. Deutetrabenazine Oral Capsule

    Teva Pharma GmbH

    Tardive Dyskinesia

    approved small molecule active

    1 trial

  15. Digoxin

    Teva Pharma GmbH

    Heart Failure

    approved small molecule completed

    1 trial

  16. Fentanyl Buccal Tablet (FBT)

    Teva Pharma GmbH

    Cancer Pain

    approved small molecule terminated

    1 trial

  17. Fluticasone propionate/salmeterol (FS)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  18. Fremanezumab

    Teva Pharma GmbH

    Migraine

    approved small molecule active

    9 trials

  19. Fremanezumab Prefilled Syringe [Ajovy]

    Teva Pharma GmbH

    Migraine Disorders

    approved small molecule terminated

    1 trial

  20. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials

  21. Ketamine

    Teva Pharma GmbH

    Treatment Resistant Depression

    approved small molecule active

    1 trial

  22. Naproxen

    Teva Pharma GmbH

    Menorrhagia

    approved small molecule completed

    1 trial

  23. Qvar

    Teva Pharma GmbH

    Asthma

    approved small molecule terminated

    2 trials

  24. Qvar® (beclometasone dipropionate HFA)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  25. Rasagiline

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule active

    5 trials

  26. Rasagiline

    Teva Pharma GmbH

    Depressive Symptoms

    approved small molecule completed

    1 trial

  27. Rasagiline

    Teva Pharma GmbH

    Sleep Disturbances

    approved small molecule completed

    1 trial

  28. Rasagiline Mesylate

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    8 trials

  29. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial

  30. Reslizumab

    Teva Pharma GmbH

    Asthma

    approved small molecule active

    5 trials

  31. Reslizumab

    Teva Pharma GmbH

    Asthma; Eosinophilic

    approved mab completed

    1 trial

  32. SCE-B

    Teva Pharma GmbH

    Nocturnal Vasomotor Symptoms

    approved small molecule completed

    1 trial

  33. Shared Solutions® plus MS Center v. Shared Solutions®

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  34. T-jet® containing TevTropin®

    Teva Pharma GmbH

    Growth Hormone Deficiency

    approved other completed

    1 trial

  35. armodafinil

    Teva Pharma GmbH

    Sleep Disorders

    approved small molecule completed

    1 trial

  36. diclofenac sodium topical gel

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  37. glatiramer acetate

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule active

    2 trials

  38. glatiramer acetate injection with oral cetirizine hydrochloride

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  39. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Teva Pharma have?

39 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.